Citizens & Northern Corporation (CZNC)

G1 Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest Income on Loans	118.64	117.23	102.52	81.29	76.7	69.48
Interest Income on Investments	11.94	10.85	10.98	11.36	7.8	7.68
Total Interest Income	130.58	128.08	113.5	92.65	84.5	77.16
Interest Paid on Deposits	39.87	39.2	24.23	6.64	4.54	7.23
Interest Paid on Borrowings	8.96	9.76	8.87	2.88	2.02	2.36
Total Interest Expense	48.83	48.96	33.1	9.52	6.56	9.6
Net Interest Income	81.75	79.12	80.4	83.13	77.94	67.57
Net Interest Income Growth (YoY)	5.15%	-1.60%	-3.28%	6.66%	15.35%	24.00%
Trust Income	8.09	7.93	7.41	6.99	7.23	6.32
Gain (Loss) on Sale of Investments	0	-	-3.04	0.02	0.02	0.17
Other Non-Interest Income	14.55	14.26	13.75	11.64	10.56	8.39
Total Non-Interest Income	29.83	29.21	24.42	24.43	25.88	24.51
Non-Interest Income Growth (YoY)	11.74%	19.63%	-0.06%	-5.60%	5.58%	26.96%
Revenues Before Loan Losses	111.58	108.32	104.82	107.56	103.82	92.08
Provision for Loan Losses	3.27	2.2	0.19	7.26	3.66	3.91
Revenue	108.31	106.13	104.63	100.31	100.16	88.17
Revenue Growth (YoY)	4.96%	1.43%	4.31%	0.15%	13.60%	20.86%
Salaries and Employee Benefits	43.07	42.77	41.48	39.4	35.35	31.1
Occupancy Expenses	4.89	4.81	4.71	4.93	4.49	4.09
Selling, General & Administrative	12.72	12.77	13.44	11.84	10.89	9.34
Other Non-Interest Expense	14.3	13.91	14.52	11.78	11.74	11.08
Total Non-Interest Expense	74.97	74.26	74.15	67.96	62.47	55.61
EBT Excluding Unusual Items	33.34	31.87	30.48	32.35	37.69	32.56
Other Unusual Items	-	-	-	-	-	-1.64
Pretax Income	33.17	31.87	30.48	32.35	37.69	23.21
Income Tax Expense	6.22	5.91	6.34	5.73	7.13	3.99
Net Income	26.95	25.96	24.15	26.62	30.55	19.22
Preferred Dividends & Other Adjustments	0.23	0.21	0.19	0.24	0.24	0.12
Net Income to Common	26.72	25.75	23.96	26.38	30.31	19.11
Net Income Growth	15.80%	7.50%	-9.28%	-12.88%	58.95%	-1.45%
Basic Shares Outstanding	15	15	15	15	16	15
Diluted Shares Outstanding	15	15	15	15	16	15
Shares Change (YoY)	0.71%	0.14%	-1.40%	-1.99%	6.95%	10.70%
EPS (Basic)	1.75	1.69	1.57	1.71	1.92	1.30
EPS (Diluted)	1.75	1.69	1.57	1.71	1.92	1.30
EPS Growth	15.34%	7.45%	-8.02%	-11.10%	48.16%	-11.18%
Dividend Per Share	1.120	1.120	1.120	1.120	1.120	1.080
Dividend Growth	-	-	-	-	3.70%	-
Effective Tax Rate	18.75%	18.55%	20.78%	17.72%	18.93%	17.19%

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.

SEC Filings: 10-K · 10-Q